People living with CTEPH face significant symptoms that affect daily life, even when receiving treatment, a real-world U.S.

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...

The combination of echocardiography, N-terminal pro-B-type natriuretic peptide and pulmonary artery to ascending aorta diameter ratio predicted severe pulmonary hypertension in patients with COPD with ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...

Doctors in Germany could have achieved a breakthrough as they treated a young girl suffering from a severe pulmonary condition that can lead to heart failure, by applying umbilical cord stem cell ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...

Proceeds to fund clinical development of DIAG723, a first-in-class, disease-modifying therapy designed to correct the root cause of hereditary hemorrhagic telangiectasia and pulmonary arterial ...